North America Pharmaceuticals Market Size, Share & Industry Analysis, By Type (Drugs {Oncology, Diabetes, Infectious Diseases, Cardiology, Neurology, Respiratory, Hypertension, Anti-Obesity, Dermatology, Ophthalmology, and Others} and Vaccines {Viral Diseases and Bacterial Diseases}), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI112612

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Impact of COVID-19 on the Market
2. Overview: Influence of Trump Administration on the Industry
3. Key Challenges in the Industry
4. Overview: Promising Therapeutics Areas
5. Overview: Investment Trend in Pharma & Biotech Industry
6. Key Industry Developments – New Product Launches & Partnerships
7. Detailed Overview: Mergers & Acquisitions (Number & Size) and IPO in the Pharma/Biotech Industry in the U.S.
8. Overview: Nearing Patent Loss of Key Pharma Products
9. Overview: Future of M&A and IPOs in Pharma/Biotech Industry
10. Data on the Investment Trend for Key Therapeutic Modalities
11. Overview on the Alliance/Partnership Trends in Biopharma
North America Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Oncology
    2. Diabetes
    3. Infectious Diseases
    4. Cardiology
    5. Neurology
    6. Respiratory
    7. Hypertension
    8. Anti-Obesity
    9. Dermatology
    10. Ophthalmology
    11. Others
  2. Vaccines
    1. Viral Diseases
    2. Bacterial Diseases
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Competitive Analysis
1. North America Market Share Analysis (2024)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. GSK plc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Merck & Co., Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. AbbVie Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Bristol-Myers Squibb Company
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Impact of COVID-19 on the Market
2. Overview: Influence of Trump Administration on the Industry
3. Key Challenges in the Industry
4. Overview: Promising Therapeutics Areas
5. Overview: Investment Trend in Pharma & Biotech Industry
6. Key Industry Developments – New Product Launches & Partnerships
7. Detailed Overview: Mergers & Acquisitions (Number & Size) and IPO in the Pharma/Biotech Industry in the U.S.
8. Overview: Nearing Patent Loss of Key Pharma Products
9. Overview: Future of M&A and IPOs in Pharma/Biotech Industry
10. Data on the Investment Trend for Key Therapeutic Modalities
11. Overview on the Alliance/Partnership Trends in Biopharma
North America Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Drugs
    1. Oncology
    2. Diabetes
    3. Infectious Diseases
    4. Cardiology
    5. Neurology
    6. Respiratory
    7. Hypertension
    8. Anti-Obesity
    9. Dermatology
    10. Ophthalmology
    11. Others
  2. Vaccines
    1. Viral Diseases
    2. Bacterial Diseases
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Competitive Analysis
1. North America Market Share Analysis (2024)
2. Company Profiles
  1. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. GSK plc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Merck & Co., Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. AstraZeneca
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. F. Hoffmann-La Roche Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. AbbVie Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Bristol-Myers Squibb Company
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: North America Pharmaceuticals Market Revenue Breakdown (USD billion, %) by Country, 2024 & 2032

Figure 2: North America Pharmaceuticals Market Value Share (%), by Type, 2024 & 2032

Figure 3: North America Pharmaceuticals Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 4: North America Pharmaceuticals Market Value (USD billion), by Country, 2024 & 2032

Figure 5: North America Pharmaceuticals Market Share (%), By Company, 2024

List of Tables

Table 1: North America Pharmaceuticals Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: North America Pharmaceuticals Market Revenue (USD billion) Forecast, by Drugs, 2019–2032

Table 3: North America Pharmaceuticals Market Revenue (USD billion) Forecast, by Vaccines, 2019–2032

Table 4: North America Pharmaceuticals Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 5: North America Pharmaceuticals Market Revenue (USD billion) Forecast, by Country, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 148

(Offer valid till 15^th Dec 2025)

Download Free Sample

Security Code

Growth Advisory Services

How can we help you uncover new opportunities and scale faster?

Clients

Related Reports

Biopharmaceuticals Market

Oncology Drugs Market

Impact of Covid-19 on Pharmaceuticals Market

Antiviral Drugs Market

Vaccines Market

Diabetes Drugs Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)

sales@fortunebusinessinsights.com